Protection of 5α-dihydrotestosterone against TGF-β-induced apoptosis in FaO cells and induction of mitosis in HEPG2 cells

International Journal of Cancer

Volumn 72, Issue 2, 1997, Pages 351-355

  Lim, In Kyoung ^a   Joo, Hee Jae ^a   Choi, Kyeong Sook ^a   Sueoka, Eisaburo ^b   Lee, Myung Soog ^a   Ryu, Min Sook ^a   Fujiki, Hirota ^b  

^a Ajou University School of Medicine   (South Korea)

^b SAITAMA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; DNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL NUCLEUS; CELL PROTECTION; CELL STRAIN HEPG2; CELL VIABILITY; CHROMATIN CONDENSATION; CONTROLLED STUDY; DNA DEGRADATION; ETIOLOGY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MITOSIS; NONHUMAN; PREVENTION; PRIORITY JOURNAL; RAT; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; CELL CULTURE; DRUG EFFECT; DRUG INTERACTION; SPECIES DIFFERENCE;

ANIMALS; APOPTOSIS; DIHYDROTESTOSTERONE; DRUG INTERACTIONS; HUMANS; MITOSIS; RATS; SPECIES SPECIFICITY; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0031576071     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970717)72:2<351::AID-IJC25>3.0.CO;2-H     Document Type: Article

References (33)

1. ALEXANDROW, M.G. and MOSES, H.L., Transforming growth factor β and cell-cycle regulation. Cancer Res., 55, 1452-1457 (1995).
2. ATEN, R.F., DICKSON, R.B. and EISENFELD, A.J., Estrogen receptor in adult male rat liver. Endocrinology, 103, 1629-1635 (1978).
3. BANNISTER, P., SHERIDAN, P. and LOSOWSKY, M.S., Identification and characterization of the human hepatic androgen receptor. Clin. Endocrinol. (Oxf.), 23, 495-502 (1985).
4. BOJAR, H., WESTERKAMP, S., STAIB, W. and BROELSCH, C., Identification and partial characterization of glucocorticoid receptors in human liver. Hepatogastroenterology, 27, 176-182 (1980).
5. CALVET, X., BRUIX, J., BRU, C. GINES, P., VILANA, R., SOLE, M., AYUSO, M.C., BRUGUERA, M. and RODES, J., Natural history of hepatocellular carcinoma in Spain. Five years' experience in 249 cases. J. Hepatol., 10, 311-317 (1990).
6. CHO, H.S. and LIM, I.K., Expression of androgen receptor and its implication in hepatoma cells. Cancer Lett. (1997). (In press).
7. ETO, H., TORIYAMA, K. and ITAKURA, H.A., Clinicopathological study of hepatocellular carcinoma in Nagasaki, southwestern Japan. The association of hepatitis-B and -C viruses. Southeast Asian J. trop. Med. publ. Health, 25, 88-92 (1994).
8. FAN, G., MA, X., KREN, B.T. and STEER, C.J., The retinoblastoma gene product inhibits TGF-beta-1-induced apoptosis in primary rat hepatocytes and human Huh-7 hepatoma cells. Oncogene, 12, 1909-1919 (1996).
9. FARBER, E., Similarities in the sequence of early histological changes induced in the liver of the rat by ethionine, 2-acetyl aminofluorene and 3′-methyl-4-dimethylaminoazobenzene. Cancer Res., 16, 142-148 (1956).
10. FARINATI, F., SALVAGNINI, M., DE MARIA, N., FORNASIERO, A., CHIARAMONTE, M., ROSSARA, L. and NACCARATA, R., Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifen. J. Hepatol., 11, 297-301 (1990).
11. FATTOVICH, G. and 12 OTHERS and the EUROHEP study group on hepatitis-B virus and cirrhosis, Occurrence of hepatocellular carcinoma and decompensation in Western European patients with cirrhosis type B. Hepatology, 21, 77-82 (1995).
12. FIRMINGER, H.I. and REUBER, M.D., Influence of adrenocortical, androgenic, and anabolic hormones on the development of carcinoma and cirrhosis of the liver in AXC rats fed N-2-fluorenyldiacetamide. J. nat. Cancer Inst., 27, 559-595 (1961).
13. FUKUDA, K., KOJIRO, M. and CHIU, J-F., Induction of apoptosis by transforming-growth-factor-beta-1-induced apoptosis in rat hepatoma cell line McA-RH7777: a possible association with tissue transglutaminase expression. Hepatology, 18, 945-953 (1993).
14. GUÉCHOT, J., PEIGNEY, N., BALLET, F., VAUBOURDOLLE, M., GIBOUDEAU, J. and POUPON, R., Sex-hormone imbalance in male alcoholic cirrhotic patients with and without hepatocellular carcinoma. Cancer, 62, 760-762 (1988).
15. HANIGAN, M.H., KEMP, C.J., GINSLER, J.J. and DRINKWATER, N.R., Rapid growth of pre-neoplastic lesions in hepatocarcinogen-sensitive C3H/HeJ male mice relative to C57BL/6J male mice. Carcinogenesis, 9, 885-890 (1988).
16. LEE, H.S., HAN, C.J. and KIM, C.Y., Predominant etiologic association of hepatitis-C virus with hepatocellular carcinoma compared with hepatitis-B virus in elderly patients in a hepatitis-B-endemic area. Cancer, 72, 2564-2567 (1993).
17. 3H]methyltrienolone (R1881)-binding protein in rat liver cytosol. J. Steroid Biochem., 22, 211-219 (1985).
18. MATSUURA, B., TANIGUCHI, Y. and OHTA, Y., Effect of anti-androgen treatment on chemical hepatocarcinogenesis in rats. J. Hepatol., 21, 187-193 (1994).
19. MOORE, M.R., DRINKWATER, N.R., MILLER, E.C., MILLER, J.A. and PITOT, H.C., Quantitative analysis of the time-dependent development of glucose-6-phosphatase-deficient foci in the livers of mice treated neonatally with diethylnitrosamine. Cancer Res., 41, 1585-1593 (1981).
20. NAGASUE, N. and HITOSHI, K., Hepatocellular carcinoma and sex hormones. HPB Surgery, 6, 106 (1992).
21. NI, N. and YAGER, J.D., Comitogenic effects of estrogens on DNA synthesis induced by various growth factors in cultured female rat hepatocytes. Hepatology, 19, 183-192 (1994).
22. OBERHAMMER, F.A., BURSCH, W., PARZEFALL, W., BEIR, P., ERBER, E., STADLER, M. and SCHULTE-HERMANN, R., Effect of transforming growth factor β on cell death of cultured rat hepatocytes. Cancer Res., 51, 2478-2485 (1991).
23. OBERHAMMER, F.A., PAVELLEA, M., SHARMA, S., TIEFENBACHER, R., PURCHIO, A.F., BURSCH, W. and SCHULTE-HERMANN, R., Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. Proc. nat. Acad. Sci. (Wash.), 89, 5408-5412 (1992).
24. OBERHAMMER, F.A. and QIN, H.M., Effect of tumor promoters on the stability of hepatocyte cultures and apoptosis after transforming growth factor-β1. Carcinogenesis, 16, 1363-1371 (1995).
25. PORTER, L.E., ELM, M.S., VAN THIEL, D.H., DUGAS, M.C. and EAGON, P.K., Characterization and quantitation of human hepatic estrogen receptor. Gastroentemlogy, 84, 704-712 (1983).
26. REALDI, G., FATTOVICH, G., HADZIYANNIS, S., SCHALM, S.W., ALMASIO, P., SANCHEZ-TAPIAS, J., CHRISTENSEN, E., GIUSTINA, G. and NOVENTA, F., Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. The investigators of the European Concerted Action on Viral Hepatitis (EUROHEP). J. Hepatol., 21, 656-666 (1994).
27. RICCA-ROSELLINI, S. and MIGLIO, F., Epidemiology of hepatocellular carcinoma. Minerva Dietol. Gastroenterol., 37, 73-84 (1991).
28. SHERLOCK, S. and DOOLEY, J., Hepatic tumors. In: S. Sherlock and J. Dooley (eds.), Diseases of the liver and biliary system, pp. 503-531, Blackwell Scientific, Oxford (1993).
29. TARAO, K., OHKAWA, S., SHIMIZU, A., HARADA, M., NAKAMURA, Y. ITO, Y., TAMAI, S., HOSHINO, H., OKAMOTO, N., IMORI, K., INOUE, T. and KANISAWA, M., The male preponderance in incidence of hepatocellular carcinoma in cirrhotic patients may depend on the higher DNA synthetic activity of cirrhotic tissue in men. Cancer, 72, 369-374 (1993).
30. VESSELINOVICH, S.D., ITZE, L., MIHAILOVICH, N. and RAO, K.V. Modifying role of partial hepatectomy and gonadcctomy in ethylnitrosourea-induced hepatocarcinogenesis. Cancer Res., 40, 1538-1542 (1980).
31. VESSELINOVICH, S.D., MIHAILOVICH, N., RAO, K.V. and GOLDFARB, S., Relevance of basophilic foci to promoting effect of sex hormones on hepatocarcinosenesis. In: E. Hecker, N.E. Fusenig, W. Kunz, F. Marks and H.W. Thielmann (eds.), Carcinogenesis, Vol. 7, pp 127-131, Raven Press, New York (1982).
32. YU, M.W. and CHEN, C.J., Elevated serum testosterone levels and risk of hepatocellular carcinoma. Cancer Res., 53, 790-794 (1993).
33. YU, M.W. and CHEN, C.J., Hepatitis-B and -C viruses in the development of hepatocellular carcinoma. Crit. Rev. Oncol. Hematol., 17, 71-91 (1994).